T2DM
Conditions
Interventions
Placebo group:FTZ Simulator 4 capsules (2.52g) each time, 3 times a day
Sponsors
The First Affiliated Hospital of Guangdong Pharmaceutical University
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-60 years, gender is not limited; 2. Comply with the diagnosis of type 2 diabetes, FBG<9.0mmol/L, 2h-PBG<16.6mmol/L. 3. Agree to sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. In the past 1 month, there are diabetic ketosis, non-ketotic hyperosmolar diabetes coma, and severe infection. 2. Chronic gastrointestinal disease or chronic malnutrition, patients with anemia or abnormal hemoglobin disease. 3. Transaminase AST or ALT is greater than 2 times the upper limit of normal, serum creatinine or blood urea nitrogen is greater than the upper limit of normal. 4. Those who are allergic to FTZ or its components or intolerant. 5. Have a mental illness. 6. Women who are pregnant or breastfeeding and women who plan to have a pregnancy. 7. Took hypoglycemic drugs in the past January; 8. Patients who have participated in other drug clinical trials or are participating in other clinical trials within 3 months prior to the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| At the 12th week (or last time), assess the glycosylated albumin change or compliance rate.; | — |
Secondary
| Measure | Time frame |
|---|---|
| At 12th Week (or last) assess the fasting blood glucose, 2 hours postprandial blood glucose change or compliance rate.;the scores of TCM symptom;the scores of single TCM symptom; | — |
Countries
China
Contacts
Public ContactGuo Jiao
The First Affiliated Hospital of Guangdong Pharmaceutical University
Outcome results
None listed